1. Home
  2. ESPR vs RLGT Comparison

ESPR vs RLGT Comparison

Compare ESPR & RLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.59

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Logo Radiant Logistics Inc.

RLGT

Radiant Logistics Inc.

HOLD

Current Price

$7.34

Market Cap

327.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
RLGT
Founded
2008
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil Refining/Marketing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
731.9M
327.3M
IPO Year
2013
2006

Fundamental Metrics

Financial Performance
Metric
ESPR
RLGT
Price
$2.59
$7.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$7.60
$8.00
AVG Volume (30 Days)
5.1M
98.9K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
60.71
118.75
EPS
N/A
0.14
Revenue
$403,135,000.00
$902,696,000.00
Revenue This Year
$2.92
$2.13
Revenue Next Year
N/A
$5.18
P/E Ratio
N/A
$51.93
Revenue Growth
21.31
12.49
52 Week Low
$0.73
$5.49
52 Week High
$4.18
$8.50

Technical Indicators

Market Signals
Indicator
ESPR
RLGT
Relative Strength Index (RSI) 41.32 59.02
Support Level $2.37 $5.86
Resistance Level $3.02 $7.68
Average True Range (ATR) 0.19 0.18
MACD 0.02 0.05
Stochastic Oscillator 31.35 100.00

Price Performance

Historical Comparison
ESPR
RLGT

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About RLGT Radiant Logistics Inc.

Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.

Share on Social Networks: